.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,998,142

« Back to Dashboard

Details for Patent: 5,998,142

Title: Systematic evolution of ligands by exponential enrichment: chemi-SELEX
Abstract:This application provides methods for identifying nucleic acid ligands capable of covalently interacting with targets of interest. The nucleic acids can be associated with various functional units. The method also allows for the identification of nucleic acids that have facilitating activities as measured by their ability to facilitate formation of a covalent bond between the nucleic acid, including its associated functional unit, and its target.
Inventor(s): Gold; Larry (Boulder, CO), Eaton; Bruce (Boulder, CO), Smith; Drew (Boulder, CO), Wecker; Matthew (Boulder, CO), Jensen; Kirk (New York, NY)
Assignee: NeXstar Pharmaceuticals, Inc. (Boulder, CO)
Filing Date:Aug 21, 1997
Application Number:08/894,578
Claims:1. Nucleic acid ligands that bind covalently with a protein, wherein said nucleic acid ligands comprise a chemically reactive functional unit, wherein said nucleic acid ligands are produced by the method comprising the steps of:

a) preparing a candidate mixture of nucleic acids;

b) contacting the candidate mixture with said protein, wherein nucleic acids which bind covalently with said protein may be partitioned from the remainder of the candidate mixture;

c) partitioning the nucleic acids that bind covalently with the protein from the remainder of the candidate mixture; and

d) amplifying the nucleic acids that bind covalently with the protein, whereby nucleic acid ligands that bind covalently with the protein may be produced.

2. The nucleic acid ligands of claim 1 which are selected from the sequences listed in Table VI (SEQ ID NOS: 108-224).

3. A facilitating nucleic acid, wherein said nucleic acid comprises a chemically reactive functional unit, identified according to the method comprising the steps of:

a) preparing a candidate mixture of nucleic acids;

b) contacting the candidate mixture with a protein, wherein nucleic acids having a facilitating activity, as indicated by a covalent bond being formed between said protein and said nucleic acid, relative to the candidate mixture may be partitioned from the remainder of the candidate mixture;

c) partitioning the nucleic acids having a facilitating activity from the remainder of the candidate mixture; and

d) amplifying the nucleic acids having a facilitating activity, whereby a facilitating nucleic acid may be identified.

4. A method for partitioning nucleic acids from a nucleic acid candidate mixture, wherein said nucleic acid ligands comprise a chemically reactive functional unit, said method comprising:

a) preparing a nucleic acid candidate mixture;

b) contacting the nucleic acid candidate mixture with a protein under conditions wherein nucleic acids form a covalent bond with said protein; and

c) partitioning away the remainder of the nucleic acid candidate mixture which did not form a covalent bond with the protein, leaving only nucleic acids which have formed a covalent bond with the protein.

5. A purified and isolated non-naturally occurring nucleic acid ligand which binds covalently with a protein, wherein said nucleic acid ligand comprises a chemically reactive functional unit.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc